Impact of LDLR and PCSK9 pathogenic variants in Japanese heterozygous familial hypercholesterolemia patients.
暂无分享,去创建一个
A. Takahashi | K. Hosoda | M. Harada‐Shiba | Suguru Yamamoto | Y. Miyamoto | M. Hori | M. Ogura | Cheol Son | Naotaka Ohta | Rieko Isoda | H. Masuda